As the rising star of cell therapy biotechs, Iovance Biotherapeutics ( IOVA 3.76%) is a hot stock that's capturing a lot of ...

Earlier this month, the S&P 500 hit a record high of more than 6,000 for the first time ever. Based on that, you might assume ...

The Vanguard S&P 500 Growth Index Fund ETF Shares holds positions in top growth stocks on the S&P 500. Over the past decade, ...

One exchange-traded fund (ETF) that tracks spot Bitcoin prices is the iShares Bitcoin Trust ( IBIT 1.05%). BlackRock, the ...

Eli Lilly lost the momentum it had during the first half of the year. However, the company still has plenty of long-term ...

When it was approved in March 2024, Rezdiffra became the only medicine approved by the Food and Drug Administration (FDA) to ...

The under-the-radar components maker earned some fame when Berkshire Hathaway first bought into it in the second quarter of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The caveat is that Supermicro currently has a lot of scrutiny around its numbers. The SEC has fined the company in the past ...

In 2025, the maximum Social Security payment will be increasing from $4,873 per month to a whopping $5,108 per month. To earn ...

As Buffett advised to shareholders, being a "business picker" over a "stock picker" can protect your portfolio throughout ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...